The Immunization Clinic offers many vaccines at different costs. View our vaccine cost page for more information.

If you are ill after your trip (fever, flu-like symptoms or persistent diarrhea) we encourage you to contact your primary care provider for evaluation.

If you know which vaccinations you need for your trip you may call the clinic at 303-602-3520 to schedule your vaccination only appointment. There will be no charge for a consultation. However, prescriptions are only available with a consultation.

Yes. Prescriptions are provided with a consultation appointment only.

During our busy times consultations may be booked out for 6-8 weeks. We recommend to schedule your consultation as far in advance as possible. For questions, please call our clinic at 303-602-3520.

The travel clinic does not bill health insurance plans. However, upon payment you will receive an itemized receipt that you can submit to your insurance company.

Acceptable payment methods are cash, Visa, or MasterCard. We accept most types of insurance, and as of February 1, 2023 we do collect co-pays. We do not mail bills to your home. You may get an explanation of benefits (EOB) from your insurance company after your visit.

Patients age 18 and under can be seen without fees.

• Routine testing (persons without any symptoms):
  • For persons without insurance and over age 19, cost of testing will be $20-$90 based on a sliding scale.
• STD concerns and symptoms, treatment, family planning:
  • For persons without insurance and over age 19, fees for services are based on a sliding scale fee schedule and may range from $0-$90.

Our clinic offers appointments for Pre-Exposure Prophylaxis (PrEP), women seeking birth control options and routine testing as well. Please call 303-602-3540 to make an appointment.

1. Check-in: Get a number and paperwork from the front desk and hang onto them. We use numbers in our clinic to keep clients names confidential while in the waiting area. Have your photo ID ready. Check-in staff will see you first to determine what tests you need and assess the cost of your visit. We may need to draw blood and collect a urine sample from you.
2. Provider Visit: Your provider will ask questions to get a better idea of what additional tests you might need. The more we understand about you, the better we can help you. This visit may also include a physical exam. You may spend 30-60 minutes with the provider. If you are experiencing intimate partner violence, please talk to one of our medical providers during your visit. They can provide you with counseling and additional community resources for assistance.
3. Results and Treatment: We often make a diagnosis during your exam, and you may receive medication right away. If test results are not ready at the time of your visit, you will need to call the result line at 303-602-3540 between 2 p.m. and 4 p.m., Monday through Friday, or check MyChart.denverhealth.org for your results. If you don’t have a MyChart account, your nurse will give you login instructions. If you have a positive test result and did not receive medication at your visit, you will need to return to the clinic for treatment at no additional cost.

The Denver Sexual Health Clinic provides evaluation and testing for many sexually transmitted diseases (STDs). Your clinician will determine the appropriate tests for you. Most, but not all STDs are treated in the clinic. If needed, clinic staff can connect individuals to other sources of care.

Evaluation and Testing
We can evaluate and test for the following STDs and conditions:

• Bacterial Vaginosis
• Cervicitis
• Chlamydia
• Gonorrhea
• Hepatitis C (HCV) with same-day results
• HIV testing with same-day results
• Human Papillomavirus (HPV)
• Herpes Simplex Virus (HSNon-Gonococcal Urethritis (NGU)
• Non-Gonococcal Urethritis (NGU)
• Pelvic Inflammatory Disease (PID)
• Pregnancy
• Syphilis
• Trichomoniasis
• Urethritis

Vaccinations
Vaccinations can prevent several STDs, including:

• Hepatitis A
• Hepatitis B
• Human Papillomavirus (HPV)

We also have vaccines against Influenza (Flu). These vaccines are available at the Denver Sexual Health Clinic and/or the Immunization Clinic.

Alia Al-Tayyib, PhD, MSPH
Associate Research Scientist
Associate Professor, Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver

Dr. Alia Al-Tayyib’s primary research interests are in behavioral risks for acquiring and transmitting infections, such as HIV and hepatitis C, with a focus on the social and structural determinants of risk. Since 2007, she has served as the site PI for the National HIV Behavioral Surveillance (NHBS) system in the Denver metro area. More recently, Dr. Al-Tayyib has focused on social network studies examining the transition from oral ingestion of prescription opioids to injection drug use among at-risk youth and on developing interventions to keep people engaged in care for substance use disorders. The overarching goal of her work is to reduce the spread of infections, decrease substance use, and improve public health. Dr. Al-Tayyib currently leads the research efforts for the Denver Health Center for Addiction Medicine. She received her PhD and MSPH degrees in Epidemiology from the University of North Carolina at Chapel Hill and is an alumna of the Clinical Faculty Scholar and the Leadership for Innovative Team Science programs at the Colorado Clinical and Translational Sciences Institute.

Robert Belknap, MD
Director, Denver Metro TB Control Program
Associate Professor, Division of Infectious Diseases, School of Medicine, University of Colorado Denver

Dr. Bob Belknap’s main research interests are in identifying better ways to diagnose and treat active and latent tuberculosis. He is actively involved in the CDC-funded Tuberculosis Trials Consortium (TBTC) which investigates new treatment regimens for TB, and the Tuberculosis Epidemiologic Studies Consortium (TBESC) which works to improve tuberculosis control and elimination through a better understanding of the epidemiology and barriers to TB prevention. Dr. Belknap completed medical school at the Ohio State University College of Medicine before moving to Denver for residency in General Internal Medicine. After residency, he worked in Denver as a hospitalist for a year before completing his Infectious Diseases fellowship at the University of Colorado Denver.

William J Burman, MD
Professor, Division of Infectious Diseases, School of Medicine, University of Colorado Denver

Dr. William Burman’s primary research interest is in evaluating the impact of innovative partnerships for improving health across the community (medical care, behavioral care, social and economic support). Dr. Burman helped found the Metro Denver Partnership for Health, a collaboration of public health departments, medical care systems, and human services departments in the Denver-Boulder metro area. Dr. Burman received his medical degree from the Mayo Medical School and completed his residency at the Fitzsimons Army Medical Center. Following his residency, Dr. Burman completed an Infectious Diseases Fellowship at the University of Colorado Denver.

Edward M Gardner, MD
Director, Infectious Diseases Clinic and the Center for Positive Health
Associate Professor, Division of Infectious Diseases, School of Medicine, University of Colorado Denver

Dr. Gardner’s main areas of research interest are clinical trials for HIV and other infectious diseases, engagement in HIV care and adherence to antiretroviral therapy. Dr. Gardner is the Principal Investigator for the Infectious Disease Clinical Research Division. We participate in clinical trials sponsored by NIAID though the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) including START (Strategic Timing of AntiRetroviral Treatment) and the COVID-19 studies ACTIV-3 (Accelerating COVID-19 Therapeutic Interventions and Vaccines) and ICOS (An International Observational Study of Outpatients with COVID-19). Through the NIAID sponsored Adult AIDS Clinical Trials Group (ACTG), we are participating in REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV). Through the NCI Sponsored AIDS Malignancy Consortium (AMC), we are participating in ANCHOR (Anal Cancer/HSIL Outcomes Research Study). We also participate in several industry sponsored HIV treatment clinical trials. Dr. Gardner completed medical school at the University of Chicago - Pritzker School of Medicine and his internal medicine training at the University of North Carolina Hospitals in Chapel Hill, NC. After four years in community health and correctional medicine he completed his infectious diseases training at the University of Colorado Denver. Dr. Gardner received his Certificate in Public Health Sciences from the University of Colorado Denver.

Kellie Hawkins, MD
Attending Physician, Public Health Institute at Denver Health
Assistant Professor, Division of Infectious Diseases, School of Medicine, University of Colorado Denver

Dr. Hawkins’s research interests involve HIV treatment optimization and associated outcomes. Additionally, she is interested in engagement of individuals living with HIV, particularly those that historically have been difficult to engage. Dr. Hawkins completed medical school and a master’s in public health at New York Medical College and her internship and residency in Internal Medicine at New York Presbyterian Hospital- Columbia University. After residency, she completed an Infectious Disease fellowship at the University of Colorado Denver.

Sarah Rowan, MD
Associate Director, HIV and Viral Hepatitis Prevention
Associate Professor, Division of Infectious Diseases, School of Medicine, University of Colorado Denver

Dr. Rowan’s research focuses on optimizing public health efforts to diagnose, treat, and prevent HIV and hepatitis C (HCV). She is the co-PI for DETECT HCV, an NIH-funded multisite trial to assess screening and linkage strategies for patients with HCV in emergency department settings. She has recently led industry- and CDC-funded trials to assess screening and linkage to care approaches for HCV, HIV, and hepatitis B in community health centers, adult probations, and opioids treatment centers. She also led a same-day start HIV pre-exposure prophylaxis study that established the safety and feasibility of the same-day start approach. Dr. Rowan’s research also includes evaluation of various aspects of Covid-19 testing and the impact of Covid-19 on communities. Dr. Rowan attended medical school at the University of Oklahoma School of Medicine. She completed her residency in Internal Medicine and Pediatrics at Yale-New Haven Hospital and her fellowship in Infectious Diseases at the University of Colorado.

Kenneth Scott, PhD
Senior Epidemiologist
Assistant Professor, Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver

Dr. Scott has a broad background in public health, injury epidemiology, and informatics with specific training and expertise in using electronic health records for public health surveillance and research. Dr. Scott received his PhD in epidemiology from the Colorado School of Public Health and his MPH from the University of Washington. He completed an Applied Public Health Informatics fellowship at Denver Health.

Judith C Shlay, MD, MSPH
Associate Director, Public Health Institute at Denver Health
Professor, Department of Family Medicine, School of Medicine, University of Colorado Denver

Dr. Shlay has directed several projects focusing on focusing on health promotion and disease prevention, HIV-related metabolic and neurologic disorders, immunization delivery, reproductive health, sexually transmitted infections, substance misuse, teen pregnancy prevention, and tobacco prevention. She leads the Denver Health Center for Addiction Medicine. Dr. Shlay received her medical degree from Rush Medical College and completed residency at Cook County Hospital in Chicago, IL. She received her MSPH from the University of Colorado Denver.

Karen Wendel, MD
Director, HIV/STD Prevention and Control
Assistant Professor, Division of Infectious Diseases, School of Medicine, University of Colorado Denver

Dr. Wendel’s research is focused on the evaluation of the epidemiology of antibiotic resistant sexually transmitted infections and the efficacy of clinical STI/HIV prevention programs. Dr. Wendel works with the Denver Sexual Health Clinic and Denver Prevention Training Center to promote STD education and care in our region and improve access to HIV testing and HIV prevention services locally and nationally. Dr. Wendel received her medical degree at Johns Hopkins School of Medicine and completed an internal medicine training and infectious disease fellowship at John Hopkins Hospital.